Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator — Patent Landscape

Aggregated US Orange Book patent estate across every drug in the neuroactive steroid gamma-aminobutyric acid a receptor positive modulator class. 8 active patents protecting 1 drugs. First major cliff: 2029. Daily refresh.

1
Drugs in class
8
Active US patents
55/100
Avg vulnerability
—
Annual revenue covered

Originators

Sage Therap 8 patents

Cliff calendar — next 15 years

5
29
2
33
1
37

Drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Zulresso
BREXANOLONE
 Sage Therap 8 55 — 2029-03-13

Most attackable patents

Patent Drug Type Vuln Expiry
10251894 Zulresso method of use 62 2033-11-27
10940156 Zulresso method of use 62 2037-03-08
9750822 Zulresso formulation 55 2029-03-13
10117951 Zulresso formulation 55 2029-03-13
7635773 Zulresso formulation 55 2029-03-13
8410077 Zulresso formulation 55 2029-03-13
9200088 Zulresso formulation 55 2029-03-13
10322139 Zulresso formulation 42 2033-01-23

Strongest defences

Patent Drug Type Vuln Expiry
10322139 Zulresso formulation 42 2033-01-23
8410077 Zulresso formulation 55 2029-03-13
9200088 Zulresso formulation 55 2029-03-13
9750822 Zulresso formulation 55 2029-03-13
10117951 Zulresso formulation 55 2029-03-13
7635773 Zulresso formulation 55 2029-03-13
10940156 Zulresso method of use 62 2037-03-08
10251894 Zulresso method of use 62 2033-11-27

Related